http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2174408-C2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_21609acc78dc4c6fd029553942ba6262
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_de4667d1f44423b565b07a7bb14790fc
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-16
filingDate 1999-10-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2001-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_68cbd1124df6007b8888dd1a44123431
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_48d9a9e9f4e64d79e1f72481965181f5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5da7842a64e02b09c72611728c8bd60c
publicationDate 2001-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2174408-C2
titleOfInvention Preparation for prophylaxis and treatment of diphtheria and method of its preparing
abstract FIELD: medicine, immunology. SUBSTANCE: invention proposes the preparation that is lyophilized mono-receptor fraction of F(ab) 2 -fragments of equine IgG isolated from fermented equine hyperimmune serum using immunosorbent containing purified concentrated diphtheria anatoxin as ligand. Immunoaffine purification ensures to obtain the preparation with activity of antidiphtheria antibodies 2500 IU/ml, not less, and protein content 3-4%. For preparing the antidiphtheria preparation equine hyperimmune serum is used and for this purpose serum is fermented with pepsin followed by fractionation of proteins with salts and thermal denaturation of inert proteins. Isolation of the end product from fermented hyperimmune serum is performed by specific sorption method. EFFECT: preparing highly purified antidiphtheria preparation with decreased reactivity properties. 3 cl, 3 tbl, 2 dwg
priorityDate 1999-10-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416225075
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448670727
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP81497
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9GMY8
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419545923
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ5PY51
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10476
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3034748
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID9796
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15789
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID9796
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449846626
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00791
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00793
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP13636
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9N2D4
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00792
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9GMY7
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP11489
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00587
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9GMY6
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP27822
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5234
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP27821
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00588
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP28713
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP28712

Total number of triples: 42.